Premium Built on Growth Euphoria
INSM trades on growth hype, not business strength. The stock swings wildly—68.5% volatility is extreme. The company lives off a handful of niche drugs. One bad quarter and the rerating could be brutal.
Published by AssetNext · 2026-08-08
| Date | Signal | Peer score | Drawdown | 21d vs sector |
|---|---|---|---|---|
| 2026-08-06 | Weak profile, strong price | 38 | -37.3% | +33.1% |
| 2026-08-06 | Weak profile, strong price | 37 | -37.3% | +17.5% |
| 2026-07-30 | Weak profile, strong price | 44 | -52.0% | +15.2% |
| 2026-07-28 | Gap to peers | 43 | -50.7% | -3.4% |
| 2026-07-27 | Gap to peers | 44 | -50.5% | +3.6% |
| 2026-07-23 | Gap to peers | 43 | -49.2% | -3.7% |
| 2026-07-20 | Gap to peers | 43 | -49.4% | -4.7% |
| 2026-07-17 | Gap to peers | 35 | -48.8% | -0.5% |
Break down INSM's structural position across all peer dimensions with the interactive app.